MAKING HOPE POSSIBLE: APDA FUNDS INNOVATIVE RESEARCH
From genetic causes of PD to the neurobiology of cognitive dysfunction, APDA-funded researchers begin new work.
The American Parkinson Disease Association (APDA) recently awarded $2.6 million to support innovative Parkinson’s disease (PD) research for the 2024-2025 funding year. Exciting projects will tackle a wide range of key areas of PD research including new genetic causes of PD, the neurobiology of cognitive dysfunction in PD, and the regulation of alpha-synuclein production in the nerve cell. Projects will also tackle the underpinnings of walking dysfunction in PD, the biology behind deep brain stimulation, and more.
Each year, APDA’s Scientific Advisory Board diligently and methodically reviews grant proposals to determine the most promising and cutting-edge research to fund. It is a challenging process, approached with the utmost care.
“We have an incredible responsibility to the Parkinson’s community to choose the research that shows the most promise for real progress.”
“Additionally, we have a responsibility to our donors to use their generous support wisely, making sure every dollar counts in the search for answers,” states Leslie A. Chambers, President & CEO, APDA.
Twenty-six grants have been awarded including five Post-Doctoral Fellowships, three Diversity in PD Research grants, eight Research grants, nine Centers for Advanced Research, and one George C. Cotzias Memorial Fellowship (APDA’s most prestigious award).